Modulation of gene expression by moxonidine in rats with chronic renal failure

Nephrology Dialysis Transplantation

Volumn 19, Issue 9, 2004, Pages 2217-2222

  Vonend, Oliver ^a,c   Apel, Thomas ^a,c   Amann, Kerstin ^b,c   Sellin, Lorenz ^a,c   Stegbauer, Johannes ^a,c   Ritz, Eberhard ^b,c   Rump, Lars Christian ^a,c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

5 6 nephrectomy; Chronic renal failure; Gene expression; Moxonidine; P2 receptors; Sympathetic activity

Indexed keywords

CATHEPSIN; CYSTEINE PROTEINASE; CYTOCHROME C OXIDASE; KALLIKREIN; LEUCINE ZIPPER PROTEIN; MEGALIN; MEPRIN; MESSENGER RNA; METALLOPROTEINASE; MICROSOMAL AMINOPEPTIDASE; MOXONIDINE; NEUROTRANSMITTER; PROTEIN P21; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADAPTATION; ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CELL CULTURE; CHRONIC KIDNEY FAILURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; KIDNEY CELL; MALE; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TREATMENT OUTCOME;

EID: 4544239050     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh374     Document Type: Article

References (20)

1. Rump LC, Amann K, Orth S, Ritz E. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 2000; 15: 1735-1738
2. Hausberg M, Kosch M, Harmelink P et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106: 1974-1979
3. Amann K, Koch A, Hofstetter J et al. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers. Kidney Int 2001; 60: 1309-1323
4. Vonend O, Oberhauser V, von Kugelgen I et al. ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. Kidney Int 2002; 61: 1617-1626
5. Vonend O, Grote T, Oberhauser V, von Kugelgen I, Rump LC. P2Y-receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway. Br J Pharmacol 2003; 139: 1119-1126
6. Amann, K, Rump LC, Simonaviciene A et al. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol 2000; 11: 1469-1478
7. Megyesi J, Price PM, Tamayo E, Safirstein RL. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci USA 1999; 96: 10830-10835
8. Koh N, Fujimori T, Nishiguchi S, et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 2001; 280: 1015-1020
9. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nature Rev Mol Cell Biol 2002; 3: 256-6
10. Palmieri FE, Petrelli JJ, Ward, PE. Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides. Biochem Pharmacol 1985; 34: 2309-2317
11. Fink L, Seeger W, Ermert L et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Med 1998; 4: 1329-1333
12. Scheuermann RH and Bauer SR. Polymerase chain reaction-based mRNA quantification using an internal standard: analysis of oncogene expression. Methods Enzymol 1993; 218: 446-473
13. Ligtenberg G, Blankestijn PJ, Oey PL. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340: 1321-1328
14. Vonend O, Marsalek P, Russ H et al. Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertens 2003; 21: 1709-1717
15. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301
16. Shankland SJ, Eitner F, Hudkins KL. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000; 58: 674-683
17. Takeshita K, Fujimori T, Kurotaki Y et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 2004; 109: 1776-1782
18. Hou M, Malmsjo M, Moller S et al. Increase in cardiac P2X1- and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci 1999; 65: 1195-1206
19. Hou M, Moller S, Edvinsson L, Erlinge D. Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol 2000; 20: 2064-2069
20. Smyth DD and Penner SB. Imidazoline receptor mediated natriuresis: central and/or peripheral effect? J Auton Nerv Syst 1998; 72: 155-162